ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,274Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 3647

$1.42M Total Retail Price of All Prescriptions

Rank: 85 out of 3647

790 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 790 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 790 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 23,683 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 1,278 1,183 1 2
OMEPRAZOLE 1,197 1,064 2 3
SIMVASTATIN 1,099 994 3 1
LEVOTHYROXINE SODIUM 1,012 909 4 5
METFORMIN HCL 764 661 5 6
LISINOPRIL 640 554 6 4
CRESTOR 506 389 7 19
ATORVASTATIN CALCIUM 491 475 8 13
SERTRALINE HCL 488 464 9 27
LOSARTAN POTASSIUM 454 410 10 11
NEXIUM 452 376 11 44
GLIMEPIRIDE 442 403 12 45
FLUTICASONE PROPIONATE 433 389 13 32
DIOVAN HCT 399 365 14 80
METOPROLOL TARTRATE 375 323 15 7
LOVASTATIN 373 362 16 21
HYDROCHLOROTHIAZIDE 367 337 17 9
CLOPIDOGREL 362 342 18 26
PLAVIX 346 333 19 39
DIOVAN 337 316 20 40
ENALAPRIL MALEATE 336 304 21 35
GABAPENTIN 336 305 21 17
JANUVIA 321 290 23 72
FAMOTIDINE 318 296 24 61
CARVEDILOL 316 265 25 20
ALENDRONATE SODIUM 273 269 26 23
LOSARTAN-HYDROCHLOROTHIAZIDE 262 250 27 48
PROAIR HFA 255 216 28 62
ATENOLOL 249 239 29 10
DONEPEZIL HCL 246 246 30 30
MELOXICAM 242 230 31 33
FUROSEMIDE 241 219 32 8
METOPROLOL SUCCINATE 216 192 33 18
ZOLPIDEM TARTRATE 207 184 34 14
HYDROCODONE-ACETAMINOPHEN 200 168 S3 35 12
SINGULAIR 183 160 36 90
AZITHROMYCIN 177 148 37 34
NAMENDA 170 170 38 49
BENAZEPRIL HCL 158 149 39 71
ADVAIR DISKUS 153 135 40 52
IBUPROFEN 150 132 41 55
LIPITOR 150 143 41 113
CLONIDINE HCL 149 128 43 46
ESCITALOPRAM OXALATE 149 139 43 65
NYSTATIN 147 137 45 195
GLIPIZIDE ER 147 136 45 112
RANITIDINE HCL 146 146 47 29
ZETIA 137 129 48 96
INSULIN SYRINGE 135 127 49 76
GLYBURIDE 131 123 R 50 54
SYNTHROID 129 121 51 42
AMLODIPINE BESYLATE-BENAZEPRIL 129 101 51 74
ACTOS 126 113 53 148
PRAVASTATIN SODIUM 123 113 54 16
COMBIVENT 118 105 55 170
POTASSIUM CHLORIDE 112 104 56 24
CITALOPRAM HBR 112 101 56 25
AMOX TR-POTASSIUM CLAVULANATE 111 99 58 118
MONTELUKAST SODIUM 111 95 58 160
PANTOPRAZOLE SODIUM 105 96 60 38
WARFARIN SODIUM 101 101 61 15
TRAMADOL HCL 100 94 62 22
MECLIZINE HCL 97 94 63 85
ALLOPURINOL 96 87 64 37
ACTONEL 95 88 65 196
MOMETASONE FUROATE 94 93 66 321
AMITRIPTYLINE HCL 93 80 R 67 105
DOXAZOSIN MESYLATE 91 80 68 57
DEXILANT 89 79 69 207
VERAPAMIL ER 88 88 70 99
CIPROFLOXACIN HCL 87 79 71 53
MUPIROCIN 84 77 72 137
TAMSULOSIN HCL 84 73 72 28
KETOCONAZOLE 84 82 72 132
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 68 75 36
BENICAR HCT 82 82 76 165
GLIPIZIDE 80 79 77 41
TRIAMCINOLONE ACETONIDE 76 76 78 136
SPIRONOLACTONE 76 53 78 77
DICYCLOMINE HCL 76 59 78 194
GLIPIZIDE XL 74 70 81 190
LIDODERM 74 66 81 108
PREDNISONE 73 67 83 43
MIRTAZAPINE 72 72 84 63
FENOFIBRATE 70 41 85 50
RAMIPRIL 69 69 86 101
LYRICA 69 65 86 120
METHYLPREDNISOLONE 69 58 86 78
HUMULIN 70-30 69 69 86 192
TRAZODONE HCL 69 57 86 64
ACETAMINOPHEN-CODEINE 68 59 S3 91 149
GLYBURIDE-METFORMIN HCL 67 67 R 92 94
VOLTAREN 67 59 92 102
NYSTATIN-TRIAMCINOLONE 64 57 94 201
GEMFIBROZIL 64 36 94 82
BENICAR 63 40 96 114
FLUOXETINE HCL 61 61 97 68
CEFADROXIL 61 57 97 519
LANTUS 61 59 97 59
NAPROXEN 60 55 100 70
KLOR-CON 10 59 50 101 106
DIVALPROEX SODIUM 58 43 102 131
AVODART 58 58 102 173
VALSARTAN-HYDROCHLOROTHIAZIDE 58 53 102 423
QUETIAPINE FUMARATE 57 55 105 89
DILTIAZEM ER 56 56 106 167
FINASTERIDE 55 48 107 66
LEXAPRO 54 48 108 177
CYCLOBENZAPRINE HCL 54 42 R 108 98
ISOSORBIDE MONONITRATE ER 51 51 110 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.